Christian Nageotte, MD
Pediatric Allergy/Immunology · West Bloomfield, MINPI 1780785204
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $41,295 of the $47,176 with a category attached, or 87.5%. Regeneron Healthcare Solutions, Inc. accounts for 62.1% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $9,760, 3.8 times the $2,557 reported in 2019.
Across 106 payments — averaging $445.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$29K
- Sanofi$16K
- AstraZeneca$1K
- CSL Behring$125
- Amgen$122
- GSK$98
- plus $33 from 1 others
What the payments were for
- Consulting fees$4851%
- Speaking & faculty fees$41,29588%
- Travel & lodging$1,5503%
- Food & beverage$3,8468%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 39 | $29,311 |
| Sanofi | 15 | $16,063 |
| AstraZeneca | 47 | $1,424 |
| CSL Behring | 1 | $125 |
| Amgen | 1 | $122 |
| GSK | 1 | $98 |
| Genentech USA, Inc. | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric allergy/immunology providers in Michiganto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TakhzyroLanadelumab-Flyo | 32 | $1,443,040 |
| Dupixent PenDupilumab | 67 | $324,003 |
| XolairOmalizumab | 89 | $205,681 |
| NucalaMepolizumab | 33 | $116,636 |
| Fasenra PenBenralizumab | 22 | $112,730 |
| FasenraBenralizumab | 18 | $91,982 |
| Dupixent SyringeDupilumab | 23 | $83,500 |
| TezspireTezepelumab-Ekko | 12 | $51,204 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 100 | $20,428 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 53 | $20,275 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $18,827 |
| DuleraMometasone/Formoterol | 22 | $14,592 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $13,857 |
| Qvar RedihalerBeclomethasone Dipropionate | 40 | $13,518 |
| Advair HfaFluticasone Propion/Salmeterol | 22 | $10,870 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFasenra, Tezspire, Breztri Aerosphere, Symbicort, Pulmicort Flexhaler | $1,424 | $175,02894 claims |
| GSKNucala, Trelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $98 | $149,68290 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few pediatric allergy/immunology providers in Michiganon file to place this against a meaningful peer group, so we don't.
Other pediatric allergy/immunology in West Bloomfield
- Pavadee PoowuttikulDetroit$2K
- Amy EapenDearborn$924
- Jenny HuangDetroit$907
- Divya SethDetroit$318
- Taylor LinAnn Arbor$304
- Elizabeth SecordDetroit$274
- Steven ProperKalamazoo$258
- Amy MarksRoyal Oak$194
- Devang DoshiRoyal Oak$156
- Milind PansareDetroit$13
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.